Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Pastan

Showing results (421-430 of 829) with videos related to

Pageof 83
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|January 1, 1984
Morphologic characterization of the pathway of transferrin endocytosis and recycling in human KB cellsM C Willingham, J A Hanover, R B Dickson, et al.
Nucleic Acids Research|August 10, 1979
Partial purification and characterization of the messenger RNA for cell fibronectinJ B Fagan, K M Yamada, B de Crombrugghe, et al.
Biochemical and Biophysical Research Communications|January 15, 1988
Expression of epidermal growth factor receptor proto-oncogene mRNA in regenerating rat liverA C Johnson, S H Garfield, G T Merlino, et al.
The Journal of Biological Chemistry|July 5, 1988
Activity of immunotoxins constructed with modified Pseudomonas exotoxin A lacking the cell recognition domainT Kondo, D FitzGerald, V K Chaudhary, et al.
Cancer Research|June 1, 1991
Antitumor activity of a transforming growth factor alpha-Pseudomonas exotoxin fusion protein (TGF-alpha-PE40)L H Pai, M G Gallo, D J FitzGerald, et al.
The Journal of Biological Chemistry|March 15, 1987
A cellular 3,3',5-triiodo-L-thyronine binding protein from a human carcinoma cell line. Purification and characterizationS Kitagawa, T Obata, S Hasumura, et al.
Immunotechnology : an International Journal of Immunological Engineering|May 7, 1999
An scFv phage clone that binds to human beta2-microglobulinB Jwang, N Yerushalmi, R J Kreitman, et al.
Human Gene Therapy|June 2, 2001
An episomally maintained MDR1 gene for gene therapyC G Lee, W D Vieira, I Pastan, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 27, 2001
Cytotoxicity of antiosteosarcoma recombinant immunotoxins composed of TP-3 Fv fragments and a truncated Pseudomonas exotoxin AM Onda, T Olafsen, Y Tsutsumi, et al.
Genomics|May 20, 1999
Tissue-specific alternative splicing of the CSE1L/CAS (cellular apoptosis susceptibility) geneU Brinkmann, E Brinkmann, T K Bera, et al.
Pageof 83

Showing results (421-430 of 829) with videos related to

Sort By:
Pageof 83
Proceedings of the National Academy of Sciences of the United States of America|January 1, 1984
Morphologic characterization of the pathway of transferrin endocytosis and recycling in human KB cellsM C Willingham, J A Hanover, R B Dickson, et al.
Nucleic Acids Research|August 10, 1979
Partial purification and characterization of the messenger RNA for cell fibronectinJ B Fagan, K M Yamada, B de Crombrugghe, et al.
Biochemical and Biophysical Research Communications|January 15, 1988
Expression of epidermal growth factor receptor proto-oncogene mRNA in regenerating rat liverA C Johnson, S H Garfield, G T Merlino, et al.
The Journal of Biological Chemistry|July 5, 1988
Activity of immunotoxins constructed with modified Pseudomonas exotoxin A lacking the cell recognition domainT Kondo, D FitzGerald, V K Chaudhary, et al.
Cancer Research|June 1, 1991
Antitumor activity of a transforming growth factor alpha-Pseudomonas exotoxin fusion protein (TGF-alpha-PE40)L H Pai, M G Gallo, D J FitzGerald, et al.
The Journal of Biological Chemistry|March 15, 1987
A cellular 3,3',5-triiodo-L-thyronine binding protein from a human carcinoma cell line. Purification and characterizationS Kitagawa, T Obata, S Hasumura, et al.
Immunotechnology : an International Journal of Immunological Engineering|May 7, 1999
An scFv phage clone that binds to human beta2-microglobulinB Jwang, N Yerushalmi, R J Kreitman, et al.
Human Gene Therapy|June 2, 2001
An episomally maintained MDR1 gene for gene therapyC G Lee, W D Vieira, I Pastan, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 27, 2001
Cytotoxicity of antiosteosarcoma recombinant immunotoxins composed of TP-3 Fv fragments and a truncated Pseudomonas exotoxin AM Onda, T Olafsen, Y Tsutsumi, et al.
Genomics|May 20, 1999
Tissue-specific alternative splicing of the CSE1L/CAS (cellular apoptosis susceptibility) geneU Brinkmann, E Brinkmann, T K Bera, et al.
Pageof 83